0

    524768

    EMMESSA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    EMMESSAR BIOTECH & NUTRITION L Share Price Today

    Investment Returns

    Over 1 Month -5.08% Over 3 Months -1.96% Over 6 Months -19.13% Over 1 Year -25.78%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    EMMESSAR BIOTECH & NUTRITION L fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 12.30
    • P/E Ratio (TTM) 28.13
    • Beta 0.17
    • Book Value / share 16.24
    • Return on equity 4.23%
    • EPS (TTM) 0.87
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.03
    info icon alternate text

    EMMESSAR BIOTECH & NUTRITION L Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.09
    Operating Expense 0.49
    Net Profit 0.03
    Net Profit Margin (%) 33.33
    Earnings Per Share (EPS) 0.01
    EBITDA 0.11
    Effective Tax Rate (%) 62.50
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.09
    Operating Expense 0.45
    Net Profit 0.12
    Net Profit Margin (%) 133.33
    Earnings Per Share (EPS) 0.23
    EBITDA 0.16
    Effective Tax Rate (%) 7.69
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.09
    Operating Expense 0.49
    Net Profit 0.11
    Net Profit Margin (%) 122.22
    Earnings Per Share (EPS) 0.23
    EBITDA 0.17
    Effective Tax Rate (%) 21.42
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.09
    Operating Expense 0.40
    Net Profit 0.17
    Net Profit Margin (%) 188.88
    Earnings Per Share (EPS) 0.34
    EBITDA 0.25
    Effective Tax Rate (%) 26.08
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.10
    Operating Expense 0.44
    Net Profit -0.07
    Net Profit Margin (%) -70.00
    Earnings Per Share (EPS) -0.16
    EBITDA 0.28
    Effective Tax Rate (%) 126.92
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.37
    Operating Expense 1.82
    Net Profit 0.44
    Net Profit Margin (%) 118.91
    Earnings Per Share (EPS) 0.81
    EBITDA 0.67
    Effective Tax Rate (%) 24.13
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.61
    Operating Expense 1.66
    Net Profit 0.32
    Net Profit Margin (%) 52.45
    Earnings Per Share (EPS) 0.61
    EBITDA 1.06
    Effective Tax Rate (%) 66.66
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.56
    Operating Expense 1.73
    Net Profit 0.65
    Net Profit Margin (%) 116.07
    Earnings Per Share (EPS) 1.48
    EBITDA 0.91
    Effective Tax Rate (%) 19.75
    Particulars MAR 2023 (Values in Cr)
    Revenue 1.02
    Operating Expense 1.80
    Net Profit 0.50
    Net Profit Margin (%) 49.01
    Earnings Per Share (EPS) 0.99
    EBITDA 1.06
    Effective Tax Rate (%) 47.42
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.36
    Operating Expense 1.35
    Net Profit 0.48
    Net Profit Margin (%) 133.33
    Earnings Per Share (EPS) 0.94
    EBITDA 1.02
    Effective Tax Rate (%) 49.46
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 15.43
    ROE % 4.23
    ROCE % 11.52
    Total Debt to Total Equity 0.01
    EBITDA Margin 173.77
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 14.82
    ROE % 10.65
    ROCE % 10.31
    Total Debt to Total Equity 0.01
    EBITDA Margin 162.50
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 13.34
    ROE % 7.79
    ROCE % 13.37
    Total Debt to Total Equity 0.01
    EBITDA Margin 103.92
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 12.35
    ROE % 8.09
    ROCE % 14.16
    Total Debt to Total Equity 0.00
    EBITDA Margin 283.33
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 11.41
    ROE % 27.18
    ROCE % 37.07
    Total Debt to Total Equity 0.00
    EBITDA Margin 33.05
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 6.18
    Total Assets 8.74
    Total Liabilities 8.74
    Total Equity 7.40
    Share Outstanding 0
    Price to Book Ratio 2.01
    Return on Assets (%) 8.57
    Return on Capital (%) 9.98
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 5.19
    Total Assets 7.94
    Total Liabilities 7.94
    Total Equity 6.66
    Share Outstanding 0
    Price to Book Ratio 1.86
    Return on Assets (%) 6.34
    Return on Capital (%) 7.47
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.58
    Total Assets 7.21
    Total Liabilities 7.21
    Total Equity 6.16
    Share Outstanding 0
    Price to Book Ratio 2.23
    Return on Assets (%) 6.59
    Return on Capital (%) 7.71
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.47
    Total Assets 7.80
    Total Liabilities 7.80
    Total Equity 5.70
    Share Outstanding 0
    Price to Book Ratio 1.29
    Return on Assets (%) 18.57
    Return on Capital (%) 25.43
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 1.88
    Total Assets 6.13
    Total Liabilities 6.13
    Total Equity 4.26
    Share Outstanding 0
    Price to Book Ratio 1.34
    Return on Assets (%) 12.29
    Return on Capital (%) 17.68
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.95
    Cash from Operations 0.24
    Cash from Investing -0.22
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 0.24
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.81
    Cash from Operations 0.62
    Cash from Investing -0.64
    Cash from Financing 0.00
    Net change in Cash 0.00
    Free Cash Flow 0.62
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.96
    Cash from Operations 0.31
    Cash from Investing -0.54
    Cash from Financing 0.00
    Net change in Cash -0.17
    Free Cash Flow 0.34
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.93
    Cash from Operations 2.56
    Cash from Investing -2.61
    Cash from Financing 0.00
    Net change in Cash -0.34
    Free Cash Flow 2.86
    Particulars MAR 2021 (Values in Cr)
    Net Income 2.25
    Cash from Operations 0.56
    Cash from Investing 0.00
    Cash from Financing 0.00
    Net change in Cash 0.47
    Free Cash Flow 0.56
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ATUL LTD. 6521.60 28.32 3.08 19200.73 5563.00 7793.00
    BASF INDIA LTD 3660.50 38.07 4.00 15844.71 2906.90 5251.00
    ORIENTAL AROMATICS LIMITED 317.30 323.78 1.60 1067.83 227.05 421.60
    DEEPAK FERTILISERS & PETROCHEM 1650.95 28.27 3.04 20841.23 865.45 1776.95
    DEEPAK NITRITE LTD 1560.20 38.01 3.64 21280.04 1280.40 2006.65
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ADVANCE PETROCHEMICALS LTD. 232.00 0.00 5.25 20.88 97.60 320.75
    ATUL LTD. 6521.60 32.27 3.17 19200.73 5563.00 7793.00
    BASF INDIA LTD 3660.50 38.00 3.98 15844.71 2906.90 5251.00
    ORIENTAL AROMATICS LIMITED 317.30 42.25 1.52 1067.83 227.05 421.60

    EMMESSAR BIOTECH & NUTRITION L shareholding pattern

    Holding
    40.27%
    59.52%
    0.19%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    EMMESSAR BIOTECH & NUTRITION L Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    24.51 0.16 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 24.70
    • 26 Days 25.20
    • 10 Days 24.90
    • 50 Days 25.50
    • 12 Days 25.00
    • 100 Days 26.10
    • 20 Days 25.10
    • 200 Days 27.90
    24.76 PIVOT
    First Support 24.52 First Resistance 24.88 Second Support 24.40 Second Resistance 25.12 Third Support 24.16 Third Resistance 25.24
    RSI 44.28 ADX 17.20 MACD -0.26 Williams % R -64.07 Commodity Channel Index (CCI) -118.93
    Date 2026-07-03 Week 1017.00 Same Day 173.00 Month 1155.00
    1 Year 0.18 3 Year 0.62
    Over 1 Month
    -5.08% down
    Over 1 Year
    -25.78% down
    Over 3 Months
    -1.96% down
    Over 3 Years
    -1.54% down
    Over 6 Months
    -19.13% down
    Over 5 Years
    -7.55% down

    EMMESSAR BIOTECH & NUTRITION L Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Emmessar Biotech & Nutrition Ltd?

    Answer Field

    Emmessar Biotech & Nutrition Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 24.51 as on Jul 06 2026 09:57 AM.

    What is the Market Cap of Emmessar Biotech & Nutrition Ltd Share?

    Answer Field

    The market cap of Emmessar Biotech & Nutrition Ltd for NSE ₹ 0.00 & for BSE ₹ 12.30 as on Jul 06 2026 09:57 AM.

    What is the 52 Week High and Low of Emmessar Biotech & Nutrition Ltd?

    Answer Field

    The 52 Week High and Low of Emmessar Biotech & Nutrition Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 42.90 and ₹ 18.42.

    What is 1 year return for Emmessar Biotech & Nutrition Ltd?

    Answer Field

    The 1 year returns on the stock has been -25.78%.

    What is the P/E Ratio of Emmessar Biotech & Nutrition Ltd Share?

    Answer Field

    As on Jul 06 2026 09:57 AM the price-to-earnings (PE) ratio for Emmessar Biotech & Nutrition Ltd share is 28.13.

    What is the PB ratio of Emmessar Biotech & Nutrition Ltd Share?

    Answer Field

    As on Jul 06 2026 09:57 AM, the price-to-book (PB) ratio for Emmessar Biotech & Nutrition Ltd share is 16.24.

    How to Buy Emmessar Biotech & Nutrition Ltd Share?

    Answer Field

    You can trade in Emmessar Biotech & Nutrition Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Emmessar Biotech & Nutrition Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Emmessar Biotech & Nutrition Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Emmessar Biotech & Nutrition Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |